PROCEPT 生物机器人公司
US ˙ NasdaqGM ˙ US74276L1052

介绍

本页面提供了有关 R Kent Jr McGaughy 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示R Kent Jr McGaughy已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:PRCT / PROCEPT BioRobotics Corporation 10% Owner 2,823,681
US:RETA / Reata Pharmaceuticals Inc - Class A Director, 10% Owner 0
US:APEN / Apollo Endosurgery Inc Director, 10% Owner 0
US:TIL / Instil Bio, Inc. Director 30,000
如何解读这些图表

以下图表显示了在R Kent Jr McGaughy进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

PRCT / PROCEPT BioRobotics Corporation内部人士买入 - 短期收益分析

在这一部分,我们分析了在 PRCT / PROCEPT BioRobotics Corporation 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
2021-09-17 PRCT CPMG Inc 440,000 25.0000 440,000 25.0000 11,000,000 357 50.6500 11,286,000 102.60

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

PRCT / PROCEPT BioRobotics Corporation Insider Trades
PRCT / PROCEPT BioRobotics Corporation内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 PRCT / PROCEPT BioRobotics Corporation 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

PRCT / PROCEPT BioRobotics Corporation Insider Trades
TIL / Instil Bio, Inc.内部人士买入 - 短期收益分析

在这一部分,我们分析了在 PRCT / PROCEPT BioRobotics Corporation 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
2021-03-23 TIL McGaughy R Kent Jr 450,000 20.0000 22,500 400.0000 9,000,000 3 541.2 3,177,000 35.30

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

TIL / Instil Bio, Inc. Insider Trades
TIL / Instil Bio, Inc.内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 PRCT / PROCEPT BioRobotics Corporation 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

TIL / Instil Bio, Inc. Insider Trades
内幕交易历史

该表格显示了由 R Kent Jr McGaughy 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2024-05-07 2024-05-03 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other -1,785,127 2,823,681 -38.73
2023-09-26 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -280 0 -100.00
2023-09-26 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -4,591 0 -100.00
2023-09-26 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -2,896,901 0 -100.00
2023-09-26 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -25,004 0 -100.00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer -400,675 0 -100.00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer -63,671 0 -100.00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer -45,594 0 -100.00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer -3,687,781 0 -100.00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer -1,310,701 0 -100.00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer -675,181 0 -100.00
2023-03-07 2023-03-03 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
G - Gift -33,217 0 -100.00
2022-12-30 2022-12-28 4 APEN Apollo Endosurgery, Inc.
Class A common stock
C - Conversion 1,465,770 3,687,781 65.97 3.25 4,763,752 11,985,288
2022-12-30 2022-12-28 4 APEN Apollo Endosurgery, Inc.
Class A common stock
C - Conversion 586,308 1,310,701 80.94 3.25 1,905,501 4,259,778
2022-12-30 2022-12-28 4 APEN Apollo Endosurgery, Inc.
Class A common stock
C - Conversion 146,577 675,181 27.73 3.25 476,375 2,194,338
2022-12-07 2022-12-05 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other -1,726,534 5,029,869 -25.55
2022-11-16 2022-11-14 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other -1,729,482 6,993,137 -19.83
2022-09-13 2022-09-09 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other -986,640 8,955,675 -9.92
2022-09-08 2022-09-06 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other -743,021 10,075,491 -6.87
2022-05-25 2022-05-20 4 TIL Instil Bio, Inc.
Employee Stock Option (right to buy)
A - Award 30,000 30,000
2022-03-21 2022-03-17 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other -304,268 10,918,394 -2.71
2022-03-17 2022-03-15 4 TIL Instil Bio, Inc.
Common Stock
J - Other -260,323 8,218,467 -3.07
2022-01-05 2022-01-03 4 RETA REATA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 399 399 16.14 6,440 6,440
2021-10-19 2021-10-15 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 387,097 2,151,209 21.94 7.75 3,000,002 16,671,870
2021-10-19 2021-10-15 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 258,064 696,071 58.92 7.75 1,999,996 5,394,550
2021-10-19 2021-10-15 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 38,710 521,522 8.02 7.75 300,002 4,041,796
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Series G Convertible Preferred Stock
C - Conversion -272,205 0 -100.00
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Series F Convertible Preferred Stock
C - Conversion -2,060,802 0 -100.00
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Series E Convertible Preferred Stock
C - Conversion -3,038,934 0 -100.00
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Series D Convertible Preferred Stock
C - Conversion -4,712,969 0 -100.00
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Common Stock
P - Purchase 440,000 11,222,662 4.08 25.00 11,000,000 280,566,550
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Common Stock
C - Conversion 10,084,910 10,782,662 1,445.34
2021-09-14 3 PRCT PROCEPT BioRobotics Corp
Common Stock
697,752
2021-06-14 2021-06-10 4 RETA REATA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 690 690 83.24 57,436 57,436
2021-06-14 2021-06-10 4 RETA REATA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 5,000 5,000
2021-03-25 2021-03-23 4 TIL Instil Bio, Inc.
Series C Preferred Stock
C - Conversion -795,152 0 -100.00
2021-03-25 2021-03-23 4 TIL Instil Bio, Inc.
Series B Preferred Stock
C - Conversion -5,895,507 0 -100.00
2021-03-25 2021-03-23 4 TIL Instil Bio, Inc.
Common Stock
P - Purchase 450,000 8,478,790 5.60 20.00 9,000,000 169,575,800
2021-03-25 2021-03-23 4 TIL Instil Bio, Inc.
Common Stock
C - Conversion 954,182 8,028,790 13.49
2021-03-25 2021-03-23 4 TIL Instil Bio, Inc.
Common Stock
C - Conversion 7,074,608 7,074,608
2021-03-22 2021-03-18 4 TIL Instil Bio, Inc.
Stock Option (right to buy)
A - Award 52,000 52,000
2020-12-29 2020-12-23 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
J - Other -166,666 2,896,901 -5.44
2020-07-21 2020-07-17 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 1,200,000 1,707,208 236.59 1.25 1,500,000 2,134,010
2020-07-21 2020-07-17 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 400,000 415,244 2,623.98 1.25 500,000 519,055
2020-07-21 2020-07-17 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 180,000 477,120 60.58 1.25 225,000 596,400
2020-06-22 2020-06-10 4 RETA REATA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 699 699 82.15 57,423 57,423
2020-06-22 2020-06-10 4 RETA REATA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 6,300 6,300
2020-01-06 2020-01-02 4 APEN Apollo Endosurgery, Inc.
Class A common stock
J - Other 38,108 507,208 8.12
2020-01-06 2020-01-02 4 APEN Apollo Endosurgery, Inc.
Class A common stock
J - Other 15,244 15,244
2020-01-06 2020-01-02 4 APEN Apollo Endosurgery, Inc.
Class A common stock
J - Other 3,811 297,120 1.30
2019-12-16 2019-12-12 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
C - Conversion -30,478 0 -100.00
2019-12-16 2019-12-12 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 30,478 33,217 1,112.74
2019-11-18 2019-11-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 40,218 3,063,567 1.33 183.00 7,359,894 560,632,761
2019-08-14 2019-08-12 4 APEN Apollo Endosurgery, Inc.
6.0% Convertible Debentures due 2024
P - Purchase 4,625,000.00
2019-08-14 2019-08-12 4 APEN Apollo Endosurgery, Inc.
6.0% Convertible Debentures due 2024
P - Purchase 1,850,000.00
2019-08-14 2019-08-12 4 APEN Apollo Endosurgery, Inc.
6.0% Convertible Debentures due 2024
P - Purchase 462,500.00
2019-06-14 2019-06-12 4 RETA REATA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 892 892 57.59 51,370 51,370
2019-06-14 2019-06-12 4 RETA REATA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 9,000 9,000
2018-12-12 2018-12-12 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1,418 3,023,349 0.05 59.90 84,931 181,084,093
2018-12-12 2018-12-11 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 52,809 3,021,931 1.78 60.07 3,172,337 181,533,137
2018-12-12 2018-12-10 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 29,347 2,969,122 1.00 59.53 1,747,036 176,752,723
2018-12-12 2018-12-10 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1,078 2,939,775 0.04 58.62 63,194 172,334,902
2018-12-12 2018-12-10 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 26,174 2,938,697 0.90 57.93 1,516,336 170,247,239
2018-06-15 2018-06-13 4 RETA REATA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 1,844 1,844 26.49 48,851 48,851
2018-06-15 2018-06-13 4 RETA REATA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8,000 8,000
2017-12-29 2017-12-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 17,000 2,912,523 0.59 28.47 484,016 82,923,899
2017-12-28 2017-12-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 200 2,895,523 0.01 26.10 5,220 75,573,150
2017-12-28 2017-12-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 15,000 2,895,323 0.52 25.83 387,444 74,785,035
2017-12-28 2017-12-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 12,000 2,880,323 0.42 26.06 312,726 75,062,658
2017-12-15 2017-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 78,275 2,868,323 2.81 24.65 1,929,698 70,712,193
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 300 2,790,048 0.01 23.98 7,193 66,896,144
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 121,425 2,789,748 4.55 24.88 3,021,515 69,419,531
2017-07-26 2017-07-25 4 APEN Apollo Endosurgery, Inc.
Common Stock
P - Purchase 273,770 469,100 140.16 5.50 1,505,735 2,580,050
2017-07-26 2017-07-25 4 APEN Apollo Endosurgery, Inc.
Common Stock
P - Purchase 78,965 400,675 24.55 5.50 434,308 2,203,712
2017-07-26 2017-07-25 4 APEN Apollo Endosurgery, Inc.
Common Stock
P - Purchase 12,548 63,671 24.54 5.50 69,014 350,190
2017-07-26 2017-07-25 4 APEN Apollo Endosurgery, Inc.
Common Stock
P - Purchase 80,276 293,309 37.68 5.50 441,518 1,613,200
2017-07-26 2017-07-25 4 APEN Apollo Endosurgery, Inc.
Common Stock
P - Purchase 8,986 45,594 24.55 5.50 49,423 250,767
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
C - Conversion -742,289 1,692,857 -30.48
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
P - Purchase 1,200,000 2,435,146 97.15 25.00 30,000,000 60,878,650
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 742,289 2,668,323 38.54
2017-06-16 2017-06-14 4 RETA REATA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 3,185 3,185 17.46 55,610 55,610
2017-06-16 2017-06-14 4 RETA REATA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 6,000 6,000
2017-01-04 2016-12-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 9,392 1,926,034 0.49 21.72 204,038 41,842,511
2016-12-30 2016-12-29 4 APEN LPATH, INC
Common Stock
J - Other 195,330 195,330
2016-12-30 2016-12-29 4 APEN LPATH, INC
Common Stock
J - Other 321,710 321,710
2016-12-30 2016-12-29 4 APEN LPATH, INC
Common Stock
J - Other 51,123 51,123
2016-12-30 2016-12-29 4 APEN LPATH, INC
Common Stock
J - Other 213,033 213,033
2016-12-30 2016-12-29 4 APEN LPATH, INC
Common Stock
J - Other 36,608 36,608
2016-12-20 2016-12-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 164,753 1,916,642 9.40 22.99 3,787,820 44,065,325
2016-12-16 2016-12-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2,700 1,751,889 0.15 22.05 59,534 38,628,802
2016-12-16 2016-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 6,189 1,749,189 0.36 21.37 132,229 37,371,598
2016-12-08 2016-12-07 4 RETA REATA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 2,773 2,773 14.54 40,306 40,306
2016-12-08 2016-12-07 4 RETA REATA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 6,000 6,000
2016-08-18 2016-08-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 105,562 1,743,000 6.45 17.32 1,828,651 30,193,989
2016-08-18 2016-08-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 144,058 1,637,438 9.65 17.26 2,486,816 28,266,437
2016-08-18 2016-08-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 58,600 1,493,380 4.08 16.21 949,953 24,208,885
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 802,000 912,969 722.72 11.00 8,822,000 10,042,659
2016-06-30 2016-06-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 100,000 632,780 18.77 19.75 1,975,110 12,498,101
2016-06-30 2016-06-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 63,700 532,780 13.58 19.83 1,263,056 10,564,068
2016-06-30 2016-06-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 900 469,080 0.19 19.74 17,763 9,258,326
2016-06-28 2016-06-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 21,968 468,180 4.92 19.17 421,234 8,977,305
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 42,526 446,212 10.53 19.49 828,853 8,696,895
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 8,909 403,686 2.26 18.35 163,481 7,407,678
2016-06-08 2016-06-07 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 4,220 394,777 1.08 17.62 74,360 6,956,326
2016-06-08 2016-06-06 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 20,000 390,557 5.40 17.56 351,192 6,858,025
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 8,035 370,557 2.22 13.42 107,829 4,972,838
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -110,969 1,235,146 -8.24
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -2,739 30,478 -8.25
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -280 3,109 -8.26
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -4,591 51,095 -8.24
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -25,004 278,309 -8.24
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 23,890 362,522 7.05 14.11 336,997 5,113,808
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 6,203 338,632 1.87 14.22 88,218 4,815,990
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 28,797 332,429 9.48 13.26 381,989 4,409,637
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 8,233 303,632 2.79 13.22 108,815 4,013,074
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 127,691 295,399 76.14 12.76 1,629,899 3,770,591
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 56,739 167,708 51.13 11.43 648,305 1,916,248
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 110,969 110,969
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 2,739 2,739
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 280 280
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 4,591 4,591
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 25,004 25,004
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)